David B. Elsbree, Director at T2 Biosystems, Inc. (TTOO), bought 22,225 shares at $7.65 ($32K) on 2018-06-01, disclosed to the SEC on 2018-06-05.
Open-market purchase of $32k TTOO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.65 | 4,225 | $32K | 100.0% |
| 2 | $0.00 | 18,000 | $0 | 0.0% |
| Total | $1.45 avg | 22,225 | $32K | 100% |
| Filing → |
| TTOO | SELL | 2019-06-13 | $5K | — | Filing → |
| TTOO | BUY | 2017-11-17 | $6K | — | Filing → |
| TTOO | BUY | 2017-06-08 | $35K | — | Filing → |